Pentraxin-3 as a marker of sepsis severity and predictor of mortality outcomes: A systematic review and meta-analysis
- 1 January 2018
- journal article
- review article
- Published by Elsevier in Journal of Infection
- Vol. 76 (1) , 1-10
Abstract
No abstract availableKeywords
Funding Information
- Hong Kong Breast Cancer Foundation
This publication has 47 references indexed in Scilit:
- Pentraxin-3 Serum Levels Are Associated with Disease Severity and Mortality in Patients with Systemic Inflammatory Response SyndromePLOS ONE, 2013
- Pentraxin 3 in the assessment of ventilator-associated pneumonia: An early marker of severityHeart & Lung, 2013
- Pentraxin 3 (PTX3) Is Associated with Severe Sepsis and Fatal Disease in Emergency Room Patients with Suspected Infection: A Prospective Cohort StudyPLOS ONE, 2013
- Early detection of severe sepsis in the emergency room: Diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6Scandinavian Journal of Infectious Diseases, 2011
- High Plasma Level of Long Pentraxin 3 (PTX3) Is Associated with Fatal Disease in Bacteremic Patients: A Prospective Cohort StudyPLOS ONE, 2011
- Soluble CD40 ligand is not solely related to the presence and severity of sepsisCritical Care, 2011
- Soluble ST2 plasma concentrations predict mortality in severe sepsisIntensive Care Medicine, 2010
- Long pentraxin PTX3 is associated with mortality and disease severity in severe LeptospirosisJournal of Infection, 2009
- Common TNF-α, IL-1β, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsisBMC Infectious Diseases, 2007
- Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune responseNature, 2002